The treatment methods for pediatric urinary tract infection differ according to the etiology and clinical manifestations.
First, treatment
1. General treatment:During the acute stage, bed rest, increased fluid intake, easily digestible diet, containing sufficient calories and protein.
2. Anti-infection treatment:
(1) Drug selection: For bacterial urinary tract infections, drug selection is based on the localization diagnosis of the infection and the pathogen: ① For upper urinary tract infection, drugs with high blood and renal concentrations are selected, and for lower urinary tract infection, drugs with high urinary concentrations are selected. ② Drugs are selected based on the identified pathogen and its drug sensitivity test. ③ Low-toxic drugs should be used as much as possible. Active and effective treatment should be adopted for infants and young children, and intravenous medication is recommended for those with vomiting and apathy. Cephalosporin antibiotics, especially second and third-generation cephalosporins, have good effects. Due to the increasing trend of resistance to ampicillin (ampicillin), there is a trend to be replaced by amoxicillin/clavulanate potassium (Anmyting). Aminoglycosides should be used with caution by intravenous infusion, and the duration should not be long. Quinolone drugs have strong antibacterial effects, but they should be used with caution in children under 7 years old. Sulfamethoxazole (SMZ) and nitrofurantoin (furazolidone) are suitable for the treatment of lower urinary tract infections, generally for 5 to 7 days. Antifungal drugs can be used for urinary tract infections caused by fungi.
(2) Course of treatment: Due to the difficulty in distinguishing between clinical symptoms of pediatric cystitis and pyelonephritis, a higher proportion of neonates and infants with urinary tract infections and malformations have been observed. Short-term therapy, including single-dose therapy and 3-day therapy, is not suitable for children. Children with acute urinary tract infections treated with short-term therapy have a higher recurrence rate and the chance of re-infection than conventional therapy of about 2 weeks. Short-term therapy should only be considered for children over 5 years old with no urinary tract malformations. Acute primary upper urinary tract infection responds well to effective antibacterial treatment, with fever subsiding more than 2 to 3 days, and urine routine quickly returning to normal. The conventional course of treatment is 2 weeks. For those who do not respond well to treatment, timely replacement of antibiotics should be made based on urine culture and drug sensitivity testing, with a course lasting 4 to 6 weeks. Follow-up of midstream urine culture and colony count should be conducted at the 1st, 2nd, 3rd, 6th, and 12th months after the initial cure of urinary tract infection, for at least 1 year.
(3) Treatment for recurrence and reinfection: Acute urinary tract infection can be cured within a few days after reasonable antibacterial treatment, with symptoms usually disappearing, but 50% of children may experience recurrence, which often occurs within one month after treatment. Common causes include: ①Inappropriate selection of antibacterial drugs: This includes not choosing drugs that are sensitive to the pathogenic bacteria and only using drugs with low concentrations in renal tissue, thus failing to achieve effective杀菌目的. ②Development of drug-resistant strains: This is rare in patients with primary infection. If symptoms and bacteriuria have not disappeared within 72 hours after initial treatment, it is necessary to change antibiotics according to the results of drug sensitivity tests. ③L-form bacteria: They account for 20% of recurrent pyelonephritis. Since they can only survive in the hypertonic environment of the renal medulla, their survival environment can be destroyed by increasing fluid intake to reduce the osmotic pressure of the renal medulla. At the same time, re-treatment should be carried out with drugs that inhibit protein synthesis, such as erythromycin and chloramphenicol. ④Urolithiasis: The presence of urinary tract stones can provide a protective shelter for bacteria, allowing them to survive by escaping the killing effect of antibacterial drugs. They often become the cause of recurrence after the cessation of treatment. ⑤Pathogenic bacteria: In addition to Escherichia coli, Proteus is the most common pathogen. In boys over 1 year of age, the primary pathogen of initial infection is also Proteus. For these patients, antibiotics should be selected according to drug sensitivity tests, with high doses and long courses, at least 6 weeks. If bacteriuria persists or if frequent recurrence occurs after two treatments of more than 6 weeks, long-term low-dose antibacterial therapy should be considered, preferably taken once a day before bedtime, with a dose of 1/3 to 1/4 of the conventional treatment dose. Drugs can include sulfamethoxazole (SMZ) + trimethoprim (TMP), amoxicillin, cefalexin, or nitrofurantoin (furazolidone), or a combination of two drugs to prevent the development of drug-resistant strains. This should be continued for at least one year. Reinfection often occurs more than one month after the initial treatment and is common in girls, accounting for 80% of recurrent urinary tract infections. Reinfection is usually caused by different strains or different serotypes of Escherichia coli, often accompanied by urinary tract obstruction and vesicoureteral reflux, among other urinary tract abnormalities. For patients with reinfection, the first line of treatment should be a 10-14-day conventional treatment. If symptoms and bacteriuria disappear, follow-up with a low-dose antibiotic to prevent recurrence. The drugs available include sulfamethoxazole (SMZ) + trimethoprim (TMP), nitrofurantoin, amoxicillin, or cefalexin, with a dose of 1/4 to 1/5 of the conventional treatment dose. If the 10-14-day conventional treatment is ineffective, the course should be extended to 6 weeks. Effective patients should continue with low-dose antibiotic prophylaxis, while ineffective patients or those who initially respond but then have frequent recurrences should consider long-term low-dose antibacterial therapy, with a course of at least one year. If urinary tract abnormalities are confirmed, treatment should continue until the abnormalities are corrected or vesicoureteral reflux stops spontaneously, for at least one year after that.
(4) Treatment of asymptomatic bacteriuria: Asymptomatic bacteriuria usually does not require treatment because antibiotic treatment cannot reduce the incidence of reinfection. However, if the child has urinary tract obstruction, vesicoureteral reflux, or other urinary tract anomalies, or has left old renal scars from past infections, active treatment should be given. Otherwise, bacteriuria and coexisting anomalies can promote the development of old scars and the formation of new scars, leading to kidney function damage, renal hypertension formation, and eventually end-stage renal failure. The treatment of asymptomatic bacteriuria first adopts a 10-14 day routine therapy, followed by a low-dose long-term prevention after the bacteriuria becomes negative. The drug selection, dosage, and duration of treatment are the same as those for the prevention of recurrent infection patients.
(5) Treatment of chronic pyelonephritis: Chronic pyelonephritis often has renal cortex scarring, accompanied by deformation and expansion of renal papillae and renal pelvis calyces, or persistent renal function damage and kidney atrophy. Chronic pyelonephritis is often accompanied by vesicoureteral reflux, a few have urinary tract obstruction, and it is very rare without anomalies. The treatment of chronic pyelonephritis includes medical conservative treatment and surgical treatment. For patients with urinary tract anomalies or urinary tract obstruction, surgery should be performed as soon as possible.
(6) Treatment of urinary tract anomalies: For renal pelvis hydronephrosis caused by narrowing at the ureteropelvic junction or kidney stones, posterior urethral valves and bladder ureteral reflux grade III or above, surgical treatment should be performed.
II. Prognosis
For most children with chronic urinary tract infections, the frequency of acute attacks can be significantly reduced and the risk of renal scarring formation decreased with the correction of urinary tract anomalies and active anti-infection treatment. Only a few children with early onset of disease and extensive renal scarring at the time of visit will develop hypertension, progressive renal damage, and eventually chronic renal failure. Therefore, sufficient attention should be paid to urinary tract infections in children, especially infants and young children.